What is MOgene?
MOgene, established in 2004, is a specialized provider of precise genomic solutions tailored for research institutions, biotechnology firms, pharmaceutical companies, and government agencies. The company offers a comprehensive suite of services, including biopharma genomic services, agritech genomic services, microbiome analysis, and advanced bioinformatics. MOgene distinguishes itself through a consultative approach, providing expert guidance throughout project lifecycles to ensure high-quality outcomes for projects of varying scales. Their commitment lies in advancing agriculture and medicine through cutting-edge genomic technologies.
How much funding has MOgene raised?
MOgene has raised a total of $373K across 2 funding rounds:
Debt
$150K
Debt
$223K
Debt (2020): $150K with participation from PPP
Debt (2021): $223K led by PPP
What's next for MOgene?
The substantial capital raised, particularly the recent strategic investment, positions MOgene for significant advancements in its service offerings and market penetration. As a company operating in the late-stage funding environment, this financing is likely earmarked for scaling operations, expanding research and development initiatives, and potentially exploring new market segments within the rapidly evolving fields of genomics, agriculture, and medicine. The strategic nature of the investment suggests a focus on long-term growth and innovation, aiming to further solidify MOgene's leadership in providing advanced genomic solutions.
See full MOgene company page
